A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study

SIMPLE SUMMARY: Prostate cancer (PCa) is the second most common malignancy in males globally. Although PSA screening is a milestone in PCa detection, it also causes overdiagnosis and subsequent overtreatment. Therefore, it is imperative to find an optimal replacement or supplement for PSA testing to...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yun, Ji, Jin, Lyu, Ji, Jin, Xin, He, Xing, Mo, Shaojia, Xu, Huan, He, Jingyi, Cao, Zhi, Chen, Xi, Xu, Yalong, Wang, Lei, Wang, Fubo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393262/
https://www.ncbi.nlm.nih.gov/pubmed/34439239
http://dx.doi.org/10.3390/cancers13164075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393262/
https://www.ncbi.nlm.nih.gov/pubmed/34439239
http://dx.doi.org/10.3390/cancers13164075

Ejemplares similares